Skip to content

Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

A Novel Acceptance-Based Intervention for Anxious Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02550925
Enrollment
139
Registered
2015-09-16
Start date
2015-09-30
Completion date
2019-12-31
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer survivors

Brief summary

This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.

Interventions

A 7-session Acceptance and Commitment Therapy (ACT) group intervention

BEHAVIORALUsual Care

Check in with clinical social worker at oncology care site and obtain list of supportive resources

Sponsors

American Cancer Society, Inc.
CollaboratorOTHER
Rocky Mountain Cancer Centers
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
University of Colorado, Boulder
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Note: 139 individuals enrolled. 4 dropped out after consent, before baseline data collection, leaving 135 individuals with data.

Eligibility

Sex/Gender
ALL
Age
21 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

1. Adults in the Greater Boulder/ Denver, Colorado area who had cancer and completed primary cancer treatment (surgery, chemotherapy, and/or radiation) within the previous 18 months 2. For solid tumor cancers: Show no current evidence of disease for solid-tumor cancers (of any cancer type or initial stage). For lymphoproliferative disorders such as chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma: In remission or asymptomatic after initial treatment and are followed with active surveillance. 3. Screen positive for anxiety symptoms on the study screener 4. Able to speak, read, and write English fluently 5. Willing and able to participate in an ACT group once a week for 7 weeks 6. Willing and able to complete online questionnaires and phone interviews at designated assessment points

Exclusion criteria

1. Current moderate to high suicide risk 2. History of chronic untreated trauma (unrelated to their cancer) 3. Psychiatric hospitalization or suicide attempt in the past 5 years

Design outcomes

Primary

MeasureTime frameDescription
Anxiety symptomsBaseline to Post and (3- and 6-month) Follow UpMethod of assessment: questionnaire

Secondary

MeasureTime frameDescription
Medical resource useBaseline to Post and (3- and 6-month) Follow UpMethod of assessment: survey of medical care use
Fear of cancer recurrenceBaseline to Post and (3- and 6-month) Follow UpMethod of assessment: questionnaire
Depressive symptomsBaseline to Post and (3- and 6-month) Follow UpMethod of assessment: questionnaire
Fatigue / VitalityBaseline to Post and (3- and 6-month) Follow UpMethod of assessment: questionnaire
Anxiety disorder severityBaseline to Post and 6-month Follow UpMethod of assessment: diagnostic interview
Sense of life meaningBaseline to Post and (3- and 6-month) Follow UpMethod of assessment: questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026